Our systems are now restored following recent technical disruption, and we’re working hard to catch up on publishing. We apologise for the inconvenience caused. Find out more: https://www.cambridge.org/universitypress/about-us/news-and-blogs/cambridge-university-press-publishing-update-following-technical-disruption
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
By 2050, the number of people aged sixty years and older with schizophrenia is expected to double and affect about 10 million people worldwide. Psychoses are among the most common experiences in later life, with a lifetime risk of 23 percent. As a result, there is a looming crisis in mental health care. Schizophrenia and Psychoses in Later Life is the first major multidisciplinary reference on these important disorders. The book provides guidelines for clinical care, research and policy that are consistent with the emerging paradigmatic changes occurring with respect to schizophrenia in later life. This book features multidisciplinary contributions from experts in the fields of biological psychiatry, social psychiatry, sociology, anthropology, social work, psychology, and neuropsychology that will help professionals to integrate services and attain the best outcomes. The text will guide psychiatrists, psychologists, gerontologists, policymakers, and social scientists in creating innovative new programs to help this underserved and growing population.
'This book is a unique compendium of the major studies of aging and schizophrenia. In this way, it provides an essential resource for current understanding of the issues involved. The effort itself involves an important and often neglected area of the mental health field. The book covers the two crucial general areas, the nature of the problem of schizophrenia in later life, and the variety of programs possible for its treatment. … This broad-reaching review reminds care-givers, clinicians, researchers, and community activists of the diversity of ‘treatments’ that need to be considered and evaluated for more intelligent approaches to care.'
John Strauss - Yale University, Connecticut
Loading metrics...
* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.
Usage data cannot currently be displayed.